← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 19, 2018Last known activity
Oct 15, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (21 distinct, 16 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Recent trials (24)
- NCT06782087Sponsor investigatorPhase 1Oct 15, 2025
- NCT06782087Lead sponsorPhase 1Oct 15, 2025
- NCT07065305Sponsor investigatorEarly Phase 1Sep 15, 2025
- NCT07000058Sponsor investigatorPhase 2/Phase 3Jun 20, 2025
- NCT06999993Lead sponsorPhase 2/Phase 3Jun 20, 2025
- NCT07000058Lead sponsorPhase 2/Phase 3Jun 20, 2025
- NCT06999993Sponsor investigatorPhase 2/Phase 3Jun 20, 2025
- NCT06979791Sponsor investigatorPhase 2Jun 1, 2025
- NCT06676475Lead sponsorPhase 2/Phase 3Dec 1, 2024
- NCT06676475Sponsor investigatorPhase 2/Phase 3Dec 1, 2024
- NCT06286098OfficialPhase 3Oct 20, 2024
- NCT06595017Lead sponsorPhase 2Oct 1, 2024
- NCT06595017Sponsor investigatorPhase 2Oct 1, 2024
- NCT07138508CollaboratorPhase 1/Phase 2Mar 10, 2024
- NCT05231980CollaboratorPhase 2Jun 5, 2022
Details
- Last known activity
- Oct 15, 2025